¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diuretics"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® diuretics ÇÑ±Û ÀÌ´¢Á¦
¼³¸í   
  Na+°ú ¼öºÐÀÇ ¹è¼³À» ÃËÁø½ÃÅ´À¸·Î½á ¼Òº¯·®À» Áõ°¡½Ã۴ ¾à¹°À» ÀÌ´¢Á¦¶ó ÇÑ´Ù. Áï ¼Òº¯ÀÇ ¾çÀ» Áõ°¡½Ã۴ ¾à¹°À» ÀÌ´¢Á¦¶ó°í ÇÑ´Ù. ¼Òº¯À» »ý¼ºÇϴ °úÁ¤Àº Å©°Ô 2°¡Áö·Î ´ëº°µÈ´Ù. ¼Òº¯Àº ÄáÆÏ¿¡ ¾à 100¸¸°³ Á¸ÀçÇϴ ÄáÆÏ´ÜÀ§(nephron)À̶ó´Â ±â´ÉÀÇ ´ÜÀ§¿¡¼­ ¸¸µé¾îÁö´Âµ¥ ÀÌ ÄáÆÏ´ÜÀ§Àº Å丮¿Í ´¢¼¼°üÀ¸·Î ÀÌ·ç¾îÁø´Ù. Å丮¶õ ÄáÆÏÀ¸·Î µé¾î¿À´Â Ç÷¾×À» °É·¯³»´Â °÷À¸·Î ¿ì¼± À̰÷¿¡¼­ ÀÏ´Ü °É·¯Áø °ÍÀ» ¿ø´¢¶ó°í ÇÑ´Ù. ´¢¼¼°üÀº ÀÌ ¿ø´¢°¡ Áö³ª°¡´Â °÷À¸·Î ÀÌ ¿ø´¢¿¡¼­ ½Åü¿¡ ÇÊ¿äÇÑ ¼ººÐÀº ´Ù½Ã Ã¼³»·Î Èí¼öÇϰí Å丮¿¡¼­ °É·¯ÁöÁö ¾ÊÀº ºÒ¼ø¹°À» ºÐºñÇÏ¿© ¿ÀÁÜÀ» ¸¸µå´Â ¿ªÇÒÀ» Çϴ °÷ÀÌ´Ù. ÀÌ´¢Á¦ÀÇ ÀÛ¿ë±âÀüÀº ¿ª½Ã ÀÌ 2°¡Áö °úÁ¤¿¡ °ü°èÇϴµ¥ Å丮¿¡¼­ °É·¯Áö´Â ¿ø´¢ÀÇ ¾çÀ» Áõ°¡½Ã۴ ±âÀü°ú ¼¼´¢°ü¿¡¼­ ÀçÈí¼ö¸¦ Çϴ °úÁ¤¿¡ °ü°èÇÏ¿© ¼öºÐ°ú Na+ÀÇ ÀçÈí¼ö¸¦ ¾ïÁ¦Çϴ ±âÀüÀ¸·Î Å©°Ô ³ª´­ ¼ö°¡ ÀÖ´Ù. ÀüÀÚÀÇ ¸ÞÄ¿´ÏÁòÀ¸·Î ÀÛ¿ëÇϴ ÀÌ´¢Á¦·Î´Â ½ÉÀå¿¡¼­ ³ª¿À´Â Ç÷¾×ÀÇ ¾çÀ» Áõ°¡½ÃÄѼ­ ÄáÆÏÀÇ Å丮¸¦ Áö³ª´Â Ç÷¾×¾çÀ» Áõ°¡½ÃÄÑ ¸¹Àº Ç÷¾×À» °É·¯¼­ ¸¹Àº ¾çÀÇ ¿ø´¢¸¦ ¸¸µå´Â °­½ÉÀÌ´¢Á¦¿Í »ïÅõ¾ÐÀ» Áõ°¡½Ã۴ ¹°ÁúÀ» Åõ¿©ÇÏ¿© Å丮¿¡¼­ °É·¯Áö´Â ¾çÀ» ´ÃÀ̴ »ïÅõ¼º ÀÌ´¢Á¦ µîÀÌ ÀÖ´Ù. ÇöÀç ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ´ëºÎºÐÀÇ ÀÌ´¢Á¦µéÀº ÈÄÀÚ¿¡ ¼ÓÇÏ´Â, Áï ÄáÆÏ´¢¼¼°ü¿¡ ÀÛ¿ëÇϴ °ÍµéÀÌ´Ù.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diuretics
    ÀÌ´¢Á¦.
  • diuretics
    ÀÌ´¢Á¦,ÀÌ´¢Á¦ÀÇ
  • diuretics
    ÀÌ´¢Á¦(××Òãð¥)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • loop diuretics
    °í¸®Çü ÀÌ´¢Á¦
  • mercurial diuretics
    ¼öÀºÀÌ´¢Á¦(¡­ì¦èñð¥).
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • diuretics
    ÀÌ´¢Á¦
    ì¦Òãð¥
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
IHSS(= HCMP) Idiopathic Hypertrophic Subaortic Stenosis
  = Obstructive Idiopathic Hypertrophic Car...
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diuretics
    ÀÌ´¢Á¦
    ¼Òº¯ÀÇ ºÐºñ¸¦ ÃËÁøÇÏ´Â ¾à¹°À̳ª ¹°Áú.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cardiotonic diuretics
    °­½É ÀÌ´¢Á¦
  • loop diuretics
    °í¸® ÀÌ´¢Á¦, °èÁ¦ ÀÌ´¢Á¦, ȯ»ó ÀÌ´¢Á¦
  • osmotic diuretics
    »ïÅõ¼º ÀÌ´¢Á¦
  • related sulfonamide diuretics

    relation (À§Ä¡, °ü°è

    ¾î´À ¹°Ã¼ ¶Ç´Â ½Çü°¡ µý °Í°ú °ü·ÃÀ» °¡Áö°í ÀÖ´Ù°í »ý°¢µÇ´Â »óÅÂ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
diuretics Agents that promote the excretion of urine through their effects on kidney function.
(12 Dec 1998)
diuretics, mercurial A group of organometallic compounds, now rarely used, that promote diuresis by inhibiting tubular reabsorption of sodium and chloride.
(12 Dec 1998)
diuretics, osmotic Diuretics that are filtered at the glomerulus and reabsorbed in the renal tubule only to a limited extent. They thus increase the amount of osmotically active solute in the urine and a corresponding increase in urine volume. These compounds also increase the osmolality of plasma, thereby increasing the diffusion of water from the intraocular and cerebrospinal fluids; they can be used for reducing the pressure and volume of these fluids.
(12 Dec 1998)
diuretics, sulfamyl Diuretics containing one or more sulfonamide groups. They are similar to the benzothiazide diuretics in their pharmacological actions, but differ chemically in the nature of the heterocyclic ring.
(12 Dec 1998)
diuretics, thiazide Diuretics characterised as analogs of 1,2,4-benzothiadiazine-1,1-dioxide. All have a common mechanism of action and differ primarily in the dose required to produce a given effect. They act directly on the kidney to increase the excretion of sodium chloride and water and also increase excretion of potassium ions.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
mercurial diuretics Diuretic drugs containing organic mercury (e.g., Mercuhydrin) which promote substantial salt and water loss through the kidney. Among the first potent diuretic agents used in congestive heart failure, but now obsolescent.
(05 Mar 2000)
potassium sparing diuretics Diuretic agents that, unlike most diuretics, retain potassium; examples are triamterene and amiloride. Often used together with diuretics that promote the loss of both sodium and potassium. Used in hypertension and in congestive heart failure.
(05 Mar 2000)
osmotic diuretics Drugs, such as mannitol, which by their osmotic effects retain water during urine formation and thus dilute electrolytes in the urine, making resorption less efficient; they promote the elimination of water and electrolytes in the urine.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 2 ÆäÀÌÁö: 1
  • Diuretics - »õâ Agents that promote the excretion of urine through their effects on kidney function.
    Synonyms :
  • Diuretics, Osmotic - »õâ Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma.
    Synonyms :
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 1 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 2 ÆäÀÌÁö: 1
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á